Skip to Content

P-5883

Main Content

Transplantation and Cellular Therapy | 2023

Donor-derived malignancy and transplantation morbidity: Risks of patient and donor genetics in allogeneic hematopoietic stem cell transplantation.

Williams Lacey, Williams KM, Gillis N, Bolton K, Damm F, Deuitch NT, Farhadfar N, Gergis U, Keel SB, Michelis FV, Panch SR, Porter CC, Sucheston-Cambell L, Tamari R, Stefanski HE, Godley LA, Lai C

PubMed
PMID: 37913908

Abstract
Related Articles

CIBMTR Study #: CIBMTR_NA